Literature DB >> 6462919

Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats.

A R Kornblihtt, K Vibe-Pedersen, F E Baralle.   

Abstract

The nucleotide sequence of five independent cDNA clones, which cover 4843 nucleotides from the poly(A) addition site of human fibronectin (FN) mRNA was determined. The deduced amino acid sequence (1383 residues) covers the COOH-terminal 60% of human FN, spanning the C-terminus, fibrin-, heparin- and cell-binding domains, and shows the exact location of the only two free sulphydryl groups present in each subunit chain. We have recently reported two different FN mRNA species; one of them containing an additional 270 nucleotide insert (ED) that encodes exactly one of the homology type III repeats of the protein. The two mRNAs arise by alternative splicing of a common precursor. S1 nuclease mapping of cDNA/RNA hybrids shows that the expression of the two mRNAs is cell specific. Liver only produces the mRNA without the ED, whereas hepatoma cells, breast tumor cells and normal fibroblasts produce both forms of mRNA. Another area of alternative splicing generating three different FN mRNAs in rat liver has been reported by Schwarzbauer et al (16). We here provide evidence for the existence in human cells of a fourth mRNA species different from the three described in rat liver.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6462919      PMCID: PMC320036          DOI: 10.1093/nar/12.14.5853

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

Review 2.  Fibronectins--adhesive glycoproteins of cell surface and blood.

Authors:  K M Yamada; K Olden
Journal:  Nature       Date:  1978-09-21       Impact factor: 49.962

3.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines.

Authors:  A J Hackett; H S Smith; E L Springer; R B Owens; W A Nelson-Rees; J L Riggs; M B Gardner
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

6.  Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein.

Authors:  G Winter; S Fields
Journal:  Nucleic Acids Res       Date:  1980-05-10       Impact factor: 16.971

7.  Production of fibronectin by human epithelial cells in culture.

Authors:  H S Smith; J L Riggs; M W Mosesson
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Fibroblast cellular and plasma fibronectins are similar but not identical.

Authors:  K M Yamada; D W Kennedy
Journal:  J Cell Biol       Date:  1979-02       Impact factor: 10.539

View more
  61 in total

1.  Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.

Authors:  O Kocher; S P Kennedy; J A Madri
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  In vitro splicing of fibronectin pre-mRNAs.

Authors:  P A Norton; R O Hynes
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

3.  A TaqI RFLP for the human fibronectin (FN1) gene.

Authors:  R Gardella; M Colombi; S Barlati
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

4.  Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts.

Authors:  M Shibanuma; E Mochizuki; R Maniwa; J Mashimo; N Nishiya; S Imai; T Takano; M Oshimura; K Nose
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  SR proteins are sufficient for exon bridging across an intron.

Authors:  J M Stark; D P Bazett-Jones; M Herfort; M B Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

7.  Extra-domain B in oncofetal fibronectin structurally promotes fibrillar head-to-tail dimerization of extracellular matrix protein.

Authors:  André Schiefner; Michaela Gebauer; Arne Skerra
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

8.  Sequence analysis and in vivo expression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events.

Authors:  G Paolella; C Henchcliffe; G Sebastio; F E Baralle
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

9.  Potential proteolytic activity of human plasma fibronectin.

Authors:  V Keil-Dlouha; T Planchenault
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

10.  Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia.

Authors:  M Colombi; R Gardella; N Zoppi; L Moro; D Marini; N K Spurr; S Barlati
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.